<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18939" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cardiovascular Disease</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Olvera Lopez</surname>
            <given-names>Edgardo</given-names>
          </name>
          <aff>Haysmed, The University of Kansas Health System</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ballard</surname>
            <given-names>Brian D.</given-names>
          </name>
          <aff>McLaren Macomb Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jan</surname>
            <given-names>Arif</given-names>
          </name>
          <aff>Drexel University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Edgardo Olvera Lopez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Brian Ballard declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Arif Jan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>22</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18939.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The cardiovascular system consists of the heart and its blood vessels. A wide array of problems can arise within the cardiovascular system, a few of which include endocarditis, rheumatic heart disease, and conduction system abnormalities. Cardiovascular disease, also known as heart disease, refers to the following 4 entities: coronary artery disease (CAD) which is also referred to as coronary heart disease (CHD), cerebrovascular disease, peripheral artery disease (PAD), and aortic atherosclerosis. CAD results from decreased myocardial perfusion that causes angina due to ischemia and can result in myocardial infarction (MI), and/or heart failure. It accounts for one-third to one-half of all cases of cardiovascular disease. Cerebrovascular disease is the entity associated with strokes, also termed cerebrovascular accidents, and transient ischemic attacks (TIAs). Peripheral arterial disease (PAD) is arterial disease predominantly involving the limbs that may result in claudication. Aortic atherosclerosis is the entity associated with thoracic and abdominal aneurysms. This activity reviews the evaluation and treatment of cardiovascular disease and the role of the medical team in evaluating and treating these conditions.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the cause of coronary artery disease.</p></list-item><list-item><p>Describe the pathophysiology of atherosclerosis.</p></list-item><list-item><p>Summarize the treatment options for heart disease.</p></list-item><list-item><p>Outline the evaluation and treatment of cardiovascular disease and the role of the medical team in evaluating and treating this condition.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18939&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18939">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-18939.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The cardiovascular system consists&#x000a0;of the heart and blood vessels.<xref ref-type="bibr" rid="article-18939.r1">[1]</xref>&#x000a0;There is a wide array of problems that may arise within the&#x000a0;cardiovascular system, for example,&#x000a0;endocarditis, rheumatic heart disease, abnormalities in the conduction system, among others,&#x000a0;cardiovascular disease (CVD)&#x000a0;or heart disease refer to the following 4 entities that are the focus of this article<xref ref-type="bibr" rid="article-18939.r2">[2]</xref>:</p>
        <list list-type="order">
          <list-item>
            <p><italic toggle="yes">Coronary artery disease (CAD):</italic> Sometimes referred to as&#x000a0;Coronary Heart Disease&#x000a0;(CHD),&#x000a0;results from&#x000a0;decreased myocardial perfusion that causes angina, myocardial infarction (MI), and/or heart failure. It accounts for one-third to one-half of the cases of CVD.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Cerebrovascular disease (CVD):</italic> Including stroke and transient ischemic attack (TIA)</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Peripheral artery disease (PAD):</italic> Particularly arterial disease involving the limbs that may result in claudication</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Aortic atherosclerosis:</italic>&#x000a0;Including thoracic and abdominal aneurysms</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18939.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Although CVD may directly arise from different etiologies such as emboli in a patient with atrial fibrillation resulting in ischemic stroke, rheumatic fever causing valvular heart disease, among others, addressing risks factors associated to the development of atherosclerosis is most important because it is a common denominator in the pathophysiology of CVD.</p>
        <p>The industrialization of the economy with a resultant shift from physically demanding to sedentary jobs, along with the current consumerism and technology-driven culture that is related to longer work hours, longer commutes, and less leisure time for recreational activities, may explain the significant and steady increase in the rates of CVD during the last few decades. Specifically, physical inactivity, intake of a high-calorie diet, saturated fats, and sugars&#x000a0;are associated&#x000a0;with the development of atherosclerosis and other metabolic disturbances like metabolic syndrome, diabetes mellitus, and hypertension that are highly prevalent in people with CVD.<xref ref-type="bibr" rid="article-18939.r3">[3]</xref><xref ref-type="bibr" rid="article-18939.r2">[2]</xref><xref ref-type="bibr" rid="article-18939.r4">[4]</xref><xref ref-type="bibr" rid="article-18939.r5">[5]</xref></p>
        <p>According to the INTERHEART study that included subjects from 52 countries, including high, middle, and low-income countries, 9 modifiable risks factors accounted for 90% of the risk of having a first MI: smoking, dyslipidemia, hypertension, diabetes, abdominal obesity, psychosocial factors, consumption of fruits and vegetables, regular alcohol consumption, and physical inactivity. It is important to mention that in this study 36% of the population-attributable risk of MI was accounted to smoking.<xref ref-type="bibr" rid="article-18939.r6">[6]</xref></p>
        <p>Other large cohort studies like the Framingham Heart Study<xref ref-type="bibr" rid="article-18939.r7">[7]</xref> and the Third National Health and Nutrition Examination Survey (NHANES III)<xref ref-type="bibr" rid="article-18939.r5">[5]</xref> have also found a strong association and predictive value of dyslipidemia, high blood pressure, smoking, and glucose intolerance. Sixty percent to 90% of CHD events occurred in subjects with at least one risk factor.</p>
        <p>These findings have been translated into health promotion programs by the American Heart Association with&#x000a0;emphasis on seven recommendations to decrease the risk of CVD: avoiding smoking, being physically active, eating healthy, and keeping normal blood pressure, body weight, glucose, and cholesterol levels.<xref ref-type="bibr" rid="article-18939.r8">[8]</xref><xref ref-type="bibr" rid="article-18939.r9">[9]</xref></p>
        <p>On the other hand, non-modifiable factors as family history, age, and gender have different implications.<xref ref-type="bibr" rid="article-18939.r4">[4]</xref><xref ref-type="bibr" rid="article-18939.r7">[7]</xref> Family history, particularly&#x000a0;premature&#x000a0;atherosclerotic disease defined as CVD or death from CVD in a first-degree relative before 55 years (in males) or 65 years (in females) is considered an independent risk factor.<xref ref-type="bibr" rid="article-18939.r10">[10]</xref> There is also suggestive evidence that the presence of&#x000a0;CVD risk factors may differently influence gender.<xref ref-type="bibr" rid="article-18939.r4">[4]</xref><xref ref-type="bibr" rid="article-18939.r7">[7]</xref>&#x000a0;For instance, diabetes and smoking more than 20 cigarettes per day had increased CVD risk in women compared to men.<xref ref-type="bibr" rid="article-18939.r11">[11]</xref> Prevalence of CVD increases significantly with each decade of life.<xref ref-type="bibr" rid="article-18939.r12">[12]</xref> &#x000a0;</p>
        <p>The presence of HIV (human immunodeficiency virus),<xref ref-type="bibr" rid="article-18939.r13">[13]</xref>&#x000a0;history of mediastinal or chest wall radiation,<xref ref-type="bibr" rid="article-18939.r14">[14]</xref>&#x000a0;microalbuminuria,<xref ref-type="bibr" rid="article-18939.r15">[15]</xref>, increased inflammatory markers<xref ref-type="bibr" rid="article-18939.r16">[16]</xref><xref ref-type="bibr" rid="article-18939.r17">[17]</xref>&#x000a0;have also&#x000a0;been associated with an increased rate and incidence of CVD.&#x000a0;</p>
        <p>Pointing out specific diet factors like meat consumption, fiber, and coffee and their relation to CVD remains controversial due to significant bias and residual confounding encountered in epidemiological studies.<xref ref-type="bibr" rid="article-18939.r18">[18]</xref><xref ref-type="bibr" rid="article-18939.r19">[19]</xref></p>
      </sec>
      <sec id="article-18939.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Cardiovascular diseases (CVD) remain among the 2 leading causes of death in the United States since 1975 with 633,842 deaths or 1 in every 4 deaths, heart disease occupied the leading cause of death in 2015 followed by 595,930 deaths related to cancer.<xref ref-type="bibr" rid="article-18939.r2">[2]</xref>&#x000a0;CVD is also the number 1 cause of death globally with an estimated 17.7 million deaths in 2015, according to the World Health Organization (WHO). The burden of CVD further extends as it is considered the most costly disease even ahead of Alzheimer disease and diabetes with calculated indirect costs of $237 billion dollars per year and a projected increased to $368 billion by 2035.<xref ref-type="bibr" rid="article-18939.r20">[20]</xref></p>
        <p>Although the age-adjusted rate and acute mortality from MI have been declining over time, reflecting the progress in diagnosis and treatment during the last couple of decades, the risk of heart disease remains high with a calculated 50% risk by age 45 in the general population.<xref ref-type="bibr" rid="article-18939.r7">[7]</xref><xref ref-type="bibr" rid="article-18939.r21">[21]</xref>&#x000a0;The incidence significantly increases with age with some variations between genders as the incidence is higher in men at younger ages.<xref ref-type="bibr" rid="article-18939.r2">[2]</xref>&#x000a0;The difference in incidence narrows progressively in the post-menopausal state.<xref ref-type="bibr" rid="article-18939.r2">[2]</xref></p>
      </sec>
      <sec id="article-18939.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Atherosclerosis is the pathogenic process in the arteries and the aorta that can potentially cause disease as a consequence of decreased or absent blood flow from stenosis of the blood vessels.<xref ref-type="bibr" rid="article-18939.r22">[22]</xref></p>
        <p>It involves multiple factors dyslipidemia, immunologic phenomena, inflammation, and&#x000a0;endothelial dysfunction.&#x000a0;These factors&#x000a0;are believed to trigger the formation of fatty streak, which is the hallmark in the development of the atherosclerotic plaque<xref ref-type="bibr" rid="article-18939.r23">[23]</xref>; a progressive process that may occur as early as in the childhood.<xref ref-type="bibr" rid="article-18939.r24">[24]</xref>&#x000a0;This process comprises intimal thickening with subsequent accumulation of lipid-laden macrophages (foam cells) and extracellular matrix, followed by aggregation and proliferation of smooth muscle cells constituting the formation of the atheroma plaque.<xref ref-type="bibr" rid="article-18939.r25">[25]</xref>&#x000a0;As this lesions continue to expand, apoptosis of the deep layers can occur, precipitating further macrophage recruitment that can become calcified and transition to atherosclerotic plaques.<xref ref-type="bibr" rid="article-18939.r26">[26]</xref></p>
        <p>Other mechanisms like arterial remodeling and intra-plaque hemorrhage play an important role in the delay and accelerated the progression of atherosclerotic CVD but are beyond the purpose of this article.<xref ref-type="bibr" rid="article-18939.r27">[27]</xref></p>
      </sec>
      <sec id="article-18939.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The clinical presentation of cardiovascular diseases can range from asymptomatic (e.g., silent ischemia, angiographic evidence of coronary artery disease without symptoms, among others) to classic presentations as when&#x000a0;patients present with typical anginal chest pain consistent of myocardial infarction and/or those suffering from acute CVA presenting with focal neurological deficits of sudden onset.<xref ref-type="bibr" rid="article-18939.r28">[28]</xref><xref ref-type="bibr" rid="article-18939.r29">[29]</xref><xref ref-type="bibr" rid="article-18939.r28">[28]</xref></p>
        <p>Historically, coronary artery disease typically presents with angina that is a pain&#x000a0;of substernal location, described as a crushing or pressure in nature, that may&#x000a0;radiate&#x000a0;to the medial aspect of the left upper extremity, to the neck or the&#x000a0;jaw and that can be associated&#x000a0;with nausea, vomiting, palpitations, diaphoresis, syncope or even sudden death.<xref ref-type="bibr" rid="article-18939.r30">[30]</xref>&#x000a0;Physicians and other health care providers should be aware of&#x000a0;possible&#x000a0;variations in symptom presentation for these patients and maintain&#x000a0;a high index of suspicion despite an atypical presentation, for example,&#x000a0;dizziness and nausea as the only presenting symptoms in patients having an acute MI<xref ref-type="bibr" rid="article-18939.r31">[31]</xref>), particularly in people with a known&#x000a0;history of CAD/MI and for those with the presence of CVD risk factors.<xref ref-type="bibr" rid="article-18939.r32">[32]</xref><xref ref-type="bibr" rid="article-18939.r33">[33]</xref><xref ref-type="bibr" rid="article-18939.r34">[34]</xref><xref ref-type="bibr" rid="article-18939.r33">[33]</xref><xref ref-type="bibr" rid="article-18939.r32">[32]</xref>&#x000a0;Additional&#x000a0;chest pain features suggestive of ischemic etiology are the exacerbation with exercise and or activity and resolution with rest or nitroglycerin.<xref ref-type="bibr" rid="article-18939.r35">[35]</xref></p>
        <p>Neurologic deficits are the hallmark of cerebrovascular disease including TIA and stroke where the key differentiating factor is the resolution of symptoms within 24 hours for patients with TIA.<xref ref-type="bibr" rid="article-18939.r36">[36]</xref>&#x000a0;Although&#x000a0;the specific symptoms depend on the affected area of the brain, the sudden onset of extremity weakness, dysarthria, and facial droop are among the most commonly reported symptoms that raise concern for a diagnosis of a stroke.<xref ref-type="bibr" rid="article-18939.r37">[37]</xref><xref ref-type="bibr" rid="article-18939.r38">[38]</xref>&#x000a0;Ataxia, nystagmus and other subtle symptoms as dizziness, headache, syncope, nausea or vomiting are among the most reported symptoms with people with posterior circulation strokes challenging to correlate and that require highly suspicion in patients with risks factors.<xref ref-type="bibr" rid="article-18939.r39">[39]</xref></p>
        <p>Patients with PAD may present with claudication of the limbs, described as a cramp-like muscle pain precipitated by increased blood flow demand during exercise that typically subsides&#x000a0;with rest.<xref ref-type="bibr" rid="article-18939.r40">[40]</xref> Severe PAD might present with color changes of the skin and changes in temperature.<xref ref-type="bibr" rid="article-18939.r41">[41]</xref>&#x000a0;</p>
        <p>Most patients with thoracic aortic aneurysm will be asymptomatic, but symptoms can develop as it progresses from subtle symptoms from compression to surrounding tissues causing cough, shortness of breath or dysphonia, to the acute presentation of sudden crushing chest or back pain due to acute rupture.<xref ref-type="bibr" rid="article-18939.r42">[42]</xref>&#x000a0;The same is true for abdominal aortic aneurysms (AAA) that cause no symptoms in early stages to the acute presentation of sudden onset of abdominal pain or syncope from acute rupture.<xref ref-type="bibr" rid="article-18939.r43">[43]</xref></p>
        <p>A thorough physical examination is paramount for the diagnosis of CVD. Starting with a general inspection to look for signs of distress as in patients with angina or with decompensated heart failure, or chronic skin changes from PAD. Carotid examination with the patient on supine position and the back at 30 degrees for the palpation and auscultation of carotid pulses, bruits and to evaluate&#x000a0;for jugular venous pulsations on the neck is essential. Precordial examination starting with inspection, followed by palpation looking for chest wall tenderness, thrills, and identification of the point of maximal impulse should then be performed&#x000a0;before auscultating the precordium. Heart sounds auscultation starts in the aortic area with the identification of the S1 and S2 sounds followed by characterization of murmurs if present. Paying attention to changes with inspirations and maneuvers to correctly characterize&#x000a0;heart murmurs is encouraged. Palpating peripheral pulses with bilateral examination and comparison when applicable is an integral part of the CVD examination.<xref ref-type="bibr" rid="article-18939.r44">[44]</xref></p>
      </sec>
      <sec id="article-18939.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Thorough clinical history and physical exam directed but not limited to the cardiovascular system are the hallmarks for the diagnosis of CVD. Specifically, a history compatible with obesity, angina, decreased exercise tolerance, orthopnea, paroxysmal nocturnal dyspnea, syncope or presyncope, and claudication should prompt the clinician to obtain a more detailed history and physical exam and, if pertinent, obtain ancillary diagnostic test according to the clinical scenario (e.g., electrocardiogram and cardiac enzymes for patients presenting with chest pain).&#x000a0;</p>
        <p>Besides a diagnosis prompted by clinical suspicion, most of the efforts should be oriented for primary prevention by targeting people with the presence of risk factors and treat modifiable risk factors by all available means. All patient starting at age 20 should be engaged in the discussion of CVD risk factors and lipid measurement.<xref ref-type="bibr" rid="article-18939.r9">[9]</xref>&#x000a0;Several calculators that use LDL-cholesterol and HDL-cholesterol levels and the presence of&#x000a0;other risk factors calculate a 10-year or 30-year CVD score to determine if additional therapies like the use of statins and aspirin are indicated for primary prevention, generally indicated if such risk is more than ten percent.<xref ref-type="bibr" rid="article-18939.r10">[10]</xref>&#x000a0;Like other risk assessment tools, the use of this calculators have some&#x000a0;limitations, and it is recommended to exert precaution when assessing patients with diabetes and familial hypercholesterolemia as their risk can be underestimated. Another limitation to their use is that people older than 79 were usually excluded from the cohorts where these calculators were&#x000a0;formulated, and individualized approach for these populations is recommended by discussing risk and benefits of adjunctive therapies and particular consideration of life expectancy. Some experts recommend a reassessment of CVD risk every 4 to 6 years.<xref ref-type="bibr" rid="article-18939.r9">[9]</xref></p>
        <p>Preventative measures like following healthy food habits, avoiding overweight and following an active lifestyle are pertinent in all patients, particularly for people with non-modifiable risk factors such as family history of premature CHD or post-menopause.<xref ref-type="bibr" rid="article-18939.r9">[9]</xref><xref ref-type="bibr" rid="article-18939.r8">[8]</xref></p>
        <p>The use of inflammatory markers and other risk assessment methods as coronary artery calcification score (CAC) are under research and have limited applications that their use should not replace the identification of people with known risk factors, nonetheless these resources remain as promising tools in the future&#x000a0;of primary prevention by detecting people with subclinical atherosclerosis at risk for CVD.<xref ref-type="bibr" rid="article-18939.r45">[45]</xref></p>
      </sec>
      <sec id="article-18939.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Management of CVD is very extensive depending on the clinical situation (catheter-directed thrombolysis for acute ischemic stroke, angioplasty for peripheral vascular disease, coronary stenting for CHD); however, patients with known CVD should be strongly educated on the need for secondary prevention by risk factor and lifestyle modification.<xref ref-type="bibr" rid="article-18939.r9">[9]</xref><xref ref-type="bibr" rid="article-18939.r46">[46]</xref></p>
      </sec>
      <sec id="article-18939.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Acute pericarditis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Angina pectoris</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Artherosclerosis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Coronary artery vasospasm</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Dilated cardiomyopathy</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Giant cell arteritis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hypertension</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hypertensive heart disease</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Kawasaki disease</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Myocarditis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18939.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis and burden of CVD have been discussed in other sections.</p>
      </sec>
      <sec id="article-18939.s11" sec-type="Complications">
        <title>Complications</title>
        <p>The most feared complication from CVD is death and, as&#x000a0;explained above,&#x000a0;despite multiple discoveries in the last decades CVD remains in&#x000a0;the top leading causes of death all over the world owing to the alarming prevalence of CVD in the population.<xref ref-type="bibr" rid="article-18939.r2">[2]</xref>&#x000a0;Other complications as the need for longer hospitalizations, physical disability and increased costs of care are significant and are the focus for health-care policymakers as it is believed they will continue to increase in the coming decades.<xref ref-type="bibr" rid="article-18939.r20">[20]</xref></p>
        <p>For people with heart failure with reduced ejection fraction (HFreEF) of less than 35%, as the risk of life-threatening arrhythmias is exceedingly&#x000a0;high&#x000a0;in these patients, current guidelines recommend the implantation of an implantable-cardioverter defibrillator (ICD) for those with symptoms equivalent to a&#x000a0;New York Heart Association&#x000a0;(NYHA) Class II-IV despite&#x000a0;maximal tolerated medical therapy.<xref ref-type="bibr" rid="article-18939.r47">[47]</xref></p>
        <p>Strokes can leave people with severe disabling sequelae like dysarthria or aphasia, dysphagia, focal or generalized muscle weakness or paresis that can be temporal or cause&#x000a0;permanent physical disability that may lead to a complete bedbound state due to hemiplegia with added complications secondary to immobility as is the higher risk of developing urinary tract infections and/or risk for thromboembolic events.<xref ref-type="bibr" rid="article-18939.r48">[48]</xref><xref ref-type="bibr" rid="article-18939.r49">[49]</xref></p>
        <p>There is an increased risk of all-cause death for people with PAD compared to those without evidence of peripheral disease.<xref ref-type="bibr" rid="article-18939.r50">[50]</xref>&#x000a0;Chronic wounds, physical limitation, and limb ischemia are among other complications from PAD.<xref ref-type="bibr" rid="article-18939.r51">[51]</xref></p>
      </sec>
      <sec id="article-18939.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>An interprofessional approach that involves primary care doctors, nurses, dietitians, cardiologists, neurologists, and other specialists is likely to improve outcomes. This has&#x000a0;been shown&#x000a0;to be beneficial in patients with heart failure,<xref ref-type="bibr" rid="article-18939.r52">[52]</xref>&#x000a0;coronary disease,<xref ref-type="bibr" rid="article-18939.r53">[53]</xref>&#x000a0;and current investigations to assess the impact on other forms of CVD are under planning and promise encouraging results.</p>
      </sec>
      <sec id="article-18939.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Efforts should be directed&#x000a0;toward primary prevention by leading a healthy&#x000a0;lifestyle, and an appropriate diet starting as early as possible with the goal of delay or avoid the initiation of atherosclerosis as it relates to the future risk of CVD. The AHA developed the concept of "ideal cardiovascular health" defined by the presence of<xref ref-type="bibr" rid="article-18939.r8">[8]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Ideal health behaviors:</italic> Nonsmoking, body mass index less than 25 kg/m2, physical activity at goal levels, and&#x000a0;the pursuit&#x000a0;of&#x000a0;a diet consistent with current guideline recommendations</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Ideal health factors:</italic> Untreated total cholesterol less than 200 mg/dL, untreated blood pressure less than 120/80 mm Hg, and fasting blood glucose less than 100 mg/dL) with the goal to improve the health of all Americans with an expected decrease in deaths from CVD by 20%</p>
          </list-item>
        </list>
        <p>Specific attention should be made to people at higher risk for CVD as are people with diabetes, hypertension, hyperlipidemia, smokers, and obese patients. Risk factors modification by controlling their medical conditions, avoiding smoking, taking appropriate measures to lose weight and maintaining an active lifestyle is of extreme&#x000a0;importance.<xref ref-type="bibr" rid="article-18939.r8">[8]</xref><xref ref-type="bibr" rid="article-18939.r9">[9]</xref><xref ref-type="bibr" rid="article-18939.r10">[10]</xref> The recommendations on the use of statins and low-dose aspirin for primary and secondary prevention has been discussed in other sections.</p>
      </sec>
      <sec id="article-18939.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Cardiovascular disease generally&#x000a0;refers to 4 general entities: CAD, CVD, PVD, and aortic atherosclerosis.&#x000a0;</p>
        <p>CVD is the main cause of death globally.</p>
        <p>Measures aimed to prevent the progression of atherosclerosis are the hallmark for primary prevention of CVD.</p>
        <p>Risk factor and lifestyle modification are paramount in the prevention of CVD.</p>
      </sec>
      <sec id="article-18939.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional and patient-oriented approach can help to improve outcomes for people with cardiovascular disease as shown in patients with heart failure (HF) who had better outcomes when the&#x000a0;interprofessional&#x000a0;involvement of nurses, dietitians, pharmacists, and other health professionals was used (Class 1A).<xref ref-type="bibr" rid="article-18939.r52">[52]</xref></p>
        <p>Similarly, positive results were obtained in people in an intervention group who were followed by an interprofessional team comprised of pharmacists, nurses and a team of different physicians. This group had a&#x000a0;reduction in all-cause mortality associated with CAD by 76% compared to the control group.<xref ref-type="bibr" rid="article-18939.r53">[53]</xref>&#x000a0;Healthcare workers should educate the public on lifestyle changes and reduce the modifiable risk factors for heart disease to a minimum.</p>
      </sec>
      <sec id="article-18939.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18939&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18939">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/cardiovascular-disease/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=18939">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18939/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18939">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-18939.s17">
        <fig id="article-18939.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Atherosclerosis as a result of coronary heart disease. Contributed by National Heart, Lung and Blood Institute (NIH)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Coronary_heart_disease-atherosclerosis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-18939.s18">
        <fig id="article-18939.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Coronary Artery Disease Pathophysiology. Coronary artery disease is usually caused by an atherosclerotic plaque that blocks the lumen of a coronary artery, typically the left anterior descending artery. Contributed by&#x000a0;S Bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CAD1a" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-18939.s19">
        <title>References</title>
        <ref id="article-18939.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farley</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McLafferty</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hendry</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The cardiovascular system.</article-title>
            <source>Nurs Stand</source>
            <string-date>2012 Oct 31-Nov 6</string-date>
            <volume>27</volume>
            <issue>9</issue>
            <fpage>35</fpage>
            <page-range>35-9</page-range>
            <pub-id pub-id-type="pmid">23240514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benjamin</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Virani</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Callaway</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Chamberlain</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chiuve</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Cushman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Delling</surname>
                <given-names>FN</given-names>
              </name>
              <name>
                <surname>Deo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>de Ferranti</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Ferguson</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Fornage</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gillespie</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Isasi</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Jim&#x000e9;nez</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Jordan</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Judd</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Lackland</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lichtman</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lisabeth</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Longenecker</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Lutsey</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Mackey</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Matchar</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Matsushita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mussolino</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Nasir</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>O'Flaherty</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Palaniappan</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Pandey</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pandey</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Reeves</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Ritchey</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Rosamond</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Sampson</surname>
                <given-names>UKA</given-names>
              </name>
              <name>
                <surname>Satou</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Spartano</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Tirschwell</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Tsao</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Voeks</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Willey</surname>
                <given-names>JZ</given-names>
              </name>
              <name>
                <surname>Wilkins</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Alger</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Muntner</surname>
                <given-names>P</given-names>
              </name>
              <collab>American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee</collab>
            </person-group>
            <article-title>Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.</article-title>
            <source>Circulation</source>
            <year>2018</year>
            <month>Mar</month>
            <day>20</day>
            <volume>137</volume>
            <issue>12</issue>
            <fpage>e67</fpage>
            <page-range>e67-e492</page-range>
            <pub-id pub-id-type="pmid">29386200</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>US Preventive Services Task Force</collab>
              <name>
                <surname>Curry</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Krist</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Owens</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Caughey</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Doubeni</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Epling</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kemper</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Kubik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Landefeld</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Mangione</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Silverstein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Tseng</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US Preventive Services Task Force Recommendation Statement.</article-title>
            <source>JAMA</source>
            <year>2018</year>
            <month>Jul</month>
            <day>17</day>
            <volume>320</volume>
            <issue>3</issue>
            <fpage>272</fpage>
            <page-range>272-280</page-range>
            <pub-id pub-id-type="pmid">29998297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fox</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Coady</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sorlie</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Meigs</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>D'Agostino</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Savage</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Trends in cardiovascular complications of diabetes.</article-title>
            <source>JAMA</source>
            <year>2004</year>
            <month>Nov</month>
            <day>24</day>
            <volume>292</volume>
            <issue>20</issue>
            <fpage>2495</fpage>
            <page-range>2495-9</page-range>
            <pub-id pub-id-type="pmid">15562129</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vasan</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Sempos</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Sundstr&#x000f6;m</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kannel</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>D'Agostino</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Relative importance of borderline and elevated levels of coronary heart disease risk factors.</article-title>
            <source>Ann Intern Med</source>
            <year>2005</year>
            <month>Mar</month>
            <day>15</day>
            <volume>142</volume>
            <issue>6</issue>
            <fpage>393</fpage>
            <page-range>393-402</page-range>
            <pub-id pub-id-type="pmid">15767617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yusuf</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hawken</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ounpuu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dans</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Avezum</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lanas</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>McQueen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Budaj</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pais</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Varigos</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lisheng</surname>
                <given-names>L</given-names>
              </name>
              <collab>INTERHEART Study Investigators</collab>
            </person-group>
            <article-title>Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.</article-title>
            <source>Lancet</source>
            <year>2004</year>
            <month>Sep</month>
            <day>11-17</day>
            <volume>364</volume>
            <issue>9438</issue>
            <fpage>937</fpage>
            <page-range>937-52</page-range>
            <pub-id pub-id-type="pmid">15364185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fox</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Pencina</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Paynter</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Vasan</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>D'Agostino</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study.</article-title>
            <source>Diabetes Care</source>
            <year>2008</year>
            <month>Aug</month>
            <volume>31</volume>
            <issue>8</issue>
            <fpage>1582</fpage>
            <page-range>1582-4</page-range>
            <pub-id pub-id-type="pmid">18458146</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lloyd-Jones</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Labarthe</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mozaffarian</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Appel</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Van Horn</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Greenlund</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Daniels</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nichol</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tomaselli</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Arnett</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Fonarow</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Lauer</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Masoudi</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Robertson</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Roger</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Schwamm</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Sorlie</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Yancy</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Rosamond</surname>
                <given-names>WD</given-names>
              </name>
              <collab>American Heart Association Strategic Planning Task Force and Statistics Committee</collab>
            </person-group>
            <article-title>Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond.</article-title>
            <source>Circulation</source>
            <year>2010</year>
            <month>Feb</month>
            <day>02</day>
            <volume>121</volume>
            <issue>4</issue>
            <fpage>586</fpage>
            <page-range>586-613</page-range>
            <pub-id pub-id-type="pmid">20089546</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greenland</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Alpert</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Beller</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Benjamin</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Budoff</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Fayad</surname>
                <given-names>ZA</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hlatky</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Hodgson</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kushner</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Lauer</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Weintraub</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Wenger</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Albert</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Buller</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Creager</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Ettinger</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Guyton</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Halperin</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Hochman</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Kushner</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ohman</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Page</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Tarkington</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Yancy</surname>
                <given-names>CW</given-names>
              </name>
              <collab>American College of Cardiology Foundation</collab>
              <collab>American Heart Association</collab>
            </person-group>
            <article-title>2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2010</year>
            <month>Dec</month>
            <day>14</day>
            <volume>56</volume>
            <issue>25</issue>
            <fpage>e50</fpage>
            <page-range>e50-103</page-range>
            <pub-id pub-id-type="pmid">21144964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goff</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Lloyd-Jones</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Coady</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>D'Agostino</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Gibbons</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Greenland</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lackland</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>O'Donnell</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Shero</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Sorlie</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Jordan</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Nevo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wnek</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Halperin</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Albert</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Bozkurt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Brindis</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>DeMets</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hochman</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Kovacs</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Ohman</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Pressler</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Sellke</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Tomaselli</surname>
                <given-names>GF</given-names>
              </name>
              <collab>American College of Cardiology/American Heart Association Task Force on Practice Guidelines</collab>
            </person-group>
            <article-title>2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.</article-title>
            <source>Circulation</source>
            <year>2014</year>
            <month>Jun</month>
            <day>24</day>
            <volume>129</volume>
            <issue>25 Suppl 2</issue>
            <fpage>S49</fpage>
            <page-range>S49-73</page-range>
            <pub-id pub-id-type="pmid">24222018</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nj&#x000f8;lstad</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Arnesen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lund-Larsen</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study.</article-title>
            <source>Circulation</source>
            <year>1996</year>
            <month>Feb</month>
            <day>01</day>
            <volume>93</volume>
            <issue>3</issue>
            <fpage>450</fpage>
            <page-range>450-6</page-range>
            <pub-id pub-id-type="pmid">8565161</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Savji</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rockman</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Skolnick</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Adelman</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Riles</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2013</year>
            <month>Apr</month>
            <day>23</day>
            <volume>61</volume>
            <issue>16</issue>
            <fpage>1736</fpage>
            <page-range>1736-43</page-range>
            <pub-id pub-id-type="pmid">23500290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Currier</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boyd</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dezii</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Kawabata</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Burtcel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Maa</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Hodder</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Coronary heart disease in HIV-infected individuals.</article-title>
            <source>J Acquir Immune Defic Syndr</source>
            <year>2003</year>
            <month>Aug</month>
            <day>01</day>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>506</fpage>
            <page-range>506-12</page-range>
            <pub-id pub-id-type="pmid">12869840</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khouri</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Douglas</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Mackey</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Scherrer-Crosbie</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>LW</given-names>
              </name>
            </person-group>
            <article-title>Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues.</article-title>
            <source>Circulation</source>
            <year>2012</year>
            <month>Dec</month>
            <day>04</day>
            <volume>126</volume>
            <issue>23</issue>
            <fpage>2749</fpage>
            <page-range>2749-63</page-range>
            <pub-id pub-id-type="pmid">23212997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gerstein</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Yi</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Zinman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dinneen</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Hoogwerf</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hall&#x000e9;</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rashkow</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Joyce</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nawaz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yusuf</surname>
                <given-names>S</given-names>
              </name>
              <collab>HOPE Study Investigators</collab>
            </person-group>
            <article-title>Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.</article-title>
            <source>JAMA</source>
            <year>2001</year>
            <month>Jul</month>
            <day>25</day>
            <volume>286</volume>
            <issue>4</issue>
            <fpage>421</fpage>
            <page-range>421-6</page-range>
            <pub-id pub-id-type="pmid">11466120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Emerging Risk Factors Collaboration</collab>
              <name>
                <surname>Kaptoge</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Di Angelantonio</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lowe</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pepys</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Danesh</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.</article-title>
            <source>Lancet</source>
            <year>2010</year>
            <month>Jan</month>
            <day>09</day>
            <volume>375</volume>
            <issue>9709</issue>
            <fpage>132</fpage>
            <page-range>132-40</page-range>
            <pub-id pub-id-type="pmid">20031199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pearson</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Mensah</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Cannon</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Criqui</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fadl</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Fortmann</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Rifai</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Taubert</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tracy</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Vinicor</surname>
                <given-names>F</given-names>
              </name>
              <collab>Centers for Disease Control and Prevention</collab>
              <collab>American Heart Association</collab>
            </person-group>
            <article-title>Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.</article-title>
            <source>Circulation</source>
            <year>2003</year>
            <month>Jan</month>
            <day>28</day>
            <volume>107</volume>
            <issue>3</issue>
            <fpage>499</fpage>
            <page-range>499-511</page-range>
            <pub-id pub-id-type="pmid">12551878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trepanowski</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Ioannidis</surname>
                <given-names>JPA</given-names>
              </name>
            </person-group>
            <article-title>Perspective: Limiting Dependence on Nonrandomized Studies and Improving Randomized Trials in Human Nutrition Research: Why and How.</article-title>
            <source>Adv Nutr</source>
            <year>2018</year>
            <month>Jul</month>
            <day>01</day>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>367</fpage>
            <page-range>367-377</page-range>
            <pub-id pub-id-type="pmid">30032218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ioannidis</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Implausible results in human nutrition research.</article-title>
            <source>BMJ</source>
            <year>2013</year>
            <month>Nov</month>
            <day>14</day>
            <volume>347</volume>
            <fpage>f6698</fpage>
            <pub-id pub-id-type="pmid">24231028</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dunbar</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Khavjou</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Bakas</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kirch</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Leib</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Morrison</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Poehler</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Roger</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Whitsel</surname>
                <given-names>LP</given-names>
              </name>
              <collab>American Heart Association</collab>
            </person-group>
            <article-title>Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association.</article-title>
            <source>Circulation</source>
            <year>2018</year>
            <month>May</month>
            <day>08</day>
            <volume>137</volume>
            <issue>19</issue>
            <fpage>e558</fpage>
            <page-range>e558-e577</page-range>
            <pub-id pub-id-type="pmid">29632217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lloyd-Jones</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Larson</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Beiser</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Lifetime risk of developing coronary heart disease.</article-title>
            <source>Lancet</source>
            <year>1999</year>
            <month>Jan</month>
            <day>09</day>
            <volume>353</volume>
            <issue>9147</issue>
            <fpage>89</fpage>
            <page-range>89-92</page-range>
            <pub-id pub-id-type="pmid">10023892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Libby</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ridker</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Hansson</surname>
                <given-names>GK</given-names>
              </name>
            </person-group>
            <article-title>Progress and challenges in translating the biology of atherosclerosis.</article-title>
            <source>Nature</source>
            <year>2011</year>
            <month>May</month>
            <day>19</day>
            <volume>473</volume>
            <issue>7347</issue>
            <fpage>317</fpage>
            <page-range>317-25</page-range>
            <pub-id pub-id-type="pmid">21593864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davies</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Woolf</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rowles</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Pepper</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Morphology of the endothelium over atherosclerotic plaques in human coronary arteries.</article-title>
            <source>Br Heart J</source>
            <year>1988</year>
            <month>Dec</month>
            <volume>60</volume>
            <issue>6</issue>
            <fpage>459</fpage>
            <page-range>459-64</page-range>
            <pub-id pub-id-type="pmid">3066389</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGill</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>McMahan</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Zieske</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Tracy</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Malcom</surname>
                <given-names>GT</given-names>
              </name>
              <name>
                <surname>Herderick</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Strong</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Association of Coronary Heart Disease Risk Factors with microscopic qualities of coronary atherosclerosis in youth.</article-title>
            <source>Circulation</source>
            <year>2000</year>
            <month>Jul</month>
            <day>25</day>
            <volume>102</volume>
            <issue>4</issue>
            <fpage>374</fpage>
            <page-range>374-9</page-range>
            <pub-id pub-id-type="pmid">10908207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saiura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kunisato</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tojo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Okada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tokuhisa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hirai</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Makuuchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hirata</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nagai</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis.</article-title>
            <source>Nat Med</source>
            <year>2002</year>
            <month>Apr</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>403</fpage>
            <page-range>403-9</page-range>
            <pub-id pub-id-type="pmid">11927948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stary</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Chandler</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Dinsmore</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Fuster</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Glagov</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Insull</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Rosenfeld</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Wissler</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.</article-title>
            <source>Circulation</source>
            <year>1995</year>
            <month>Sep</month>
            <day>01</day>
            <volume>92</volume>
            <issue>5</issue>
            <fpage>1355</fpage>
            <page-range>1355-74</page-range>
            <pub-id pub-id-type="pmid">7648691</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schoenhagen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ziada</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Vince</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Nissen</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Tuzcu</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Arterial remodeling and coronary artery disease: the concept of "dilated" versus "obstructive" coronary atherosclerosis.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>297</fpage>
            <page-range>297-306</page-range>
            <pub-id pub-id-type="pmid">11499716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thaulow</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Erikssen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sandvik</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Erikssen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Jorgensen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cohn</surname>
                <given-names>PF</given-names>
              </name>
            </person-group>
            <article-title>Initial clinical presentation of cardiac disease in asymptomatic men with silent myocardial ischemia and angiographically documented coronary artery disease (the Oslo Ischemia Study).</article-title>
            <source>Am J Cardiol</source>
            <year>1993</year>
            <month>Sep</month>
            <day>15</day>
            <volume>72</volume>
            <issue>9</issue>
            <fpage>629</fpage>
            <page-range>629-33</page-range>
            <pub-id pub-id-type="pmid">8249835</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yew</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Acute stroke diagnosis.</article-title>
            <source>Am Fam Physician</source>
            <year>2009</year>
            <month>Jul</month>
            <day>01</day>
            <volume>80</volume>
            <issue>1</issue>
            <fpage>33</fpage>
            <page-range>33-40</page-range>
            <pub-id pub-id-type="pmid">19621844</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kreatsoulas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shannon</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Giacomini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Velianou</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Anand</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Reconstructing angina: cardiac symptoms are the same in women and men.</article-title>
            <source>JAMA Intern Med</source>
            <year>2013</year>
            <month>May</month>
            <day>13</day>
            <volume>173</volume>
            <issue>9</issue>
            <fpage>829</fpage>
            <page-range>829-31</page-range>
            <pub-id pub-id-type="pmid">23567974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kirchberger</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Meisinger</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Heier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kling</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wende</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Greschik</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>von Scheidt</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kuch</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Patient-reported symptoms in acute myocardial infarction: differences related to ST-segment elevation: the MONICA/KORA Myocardial Infarction Registry.</article-title>
            <source>J Intern Med</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>270</volume>
            <issue>1</issue>
            <fpage>58</fpage>
            <page-range>58-64</page-range>
            <pub-id pub-id-type="pmid">21338424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khafaji</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Suwaidi</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Atypical presentation of acute and chronic coronary artery disease in diabetics.</article-title>
            <source>World J Cardiol</source>
            <year>2014</year>
            <month>Aug</month>
            <day>26</day>
            <volume>6</volume>
            <issue>8</issue>
            <fpage>802</fpage>
            <page-range>802-13</page-range>
            <pub-id pub-id-type="pmid">25228959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ayerbe</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mathur</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Addo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wragg</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Clinical value of chest pain presentation and prodromes on the assessment of cardiovascular disease: a cohort study.</article-title>
            <source>BMJ Open</source>
            <year>2015</year>
            <month>Apr</month>
            <day>15</day>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>e007251</fpage>
            <pub-id pub-id-type="pmid">25877275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kannel</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Abbott</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study.</article-title>
            <source>N Engl J Med</source>
            <year>1984</year>
            <month>Nov</month>
            <day>01</day>
            <volume>311</volume>
            <issue>18</issue>
            <fpage>1144</fpage>
            <page-range>1144-7</page-range>
            <pub-id pub-id-type="pmid">6482932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Swap</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Nagurney</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Value and limitations of chest pain history in the evaluation of patients with suspected acute coronary syndromes.</article-title>
            <source>JAMA</source>
            <year>2005</year>
            <month>Nov</month>
            <day>23</day>
            <volume>294</volume>
            <issue>20</issue>
            <fpage>2623</fpage>
            <page-range>2623-9</page-range>
            <pub-id pub-id-type="pmid">16304077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siket</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Edlow</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Transient ischemic attack: an evidence-based update.</article-title>
            <source>Emerg Med Pract</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-26</page-range>
            <pub-id pub-id-type="pmid">23257070</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hand</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Haisma</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kwan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lindley</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Lamont</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dennis</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Wardlaw</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Interobserver agreement for the bedside clinical assessment of suspected stroke.</article-title>
            <source>Stroke</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>776</fpage>
            <page-range>776-80</page-range>
            <pub-id pub-id-type="pmid">16484609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldstein</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Simel</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Is this patient having a stroke?</article-title>
            <source>JAMA</source>
            <year>2005</year>
            <month>May</month>
            <day>18</day>
            <volume>293</volume>
            <issue>19</issue>
            <fpage>2391</fpage>
            <page-range>2391-402</page-range>
            <pub-id pub-id-type="pmid">15900010</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Searls</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Pazdera</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Korbel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vysata</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Caplan</surname>
                <given-names>LR</given-names>
              </name>
            </person-group>
            <article-title>Symptoms and signs of posterior circulation ischemia in the new England medical center posterior circulation registry.</article-title>
            <source>Arch Neurol</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>69</volume>
            <issue>3</issue>
            <fpage>346</fpage>
            <page-range>346-51</page-range>
            <pub-id pub-id-type="pmid">22083796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirsch</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Criqui</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Treat-Jacobson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Regensteiner</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Creager</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Olin</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Krook</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Hunninghake</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Comerota</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>McDermott</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Hiatt</surname>
                <given-names>WR</given-names>
              </name>
            </person-group>
            <article-title>Peripheral arterial disease detection, awareness, and treatment in primary care.</article-title>
            <source>JAMA</source>
            <year>2001</year>
            <month>Sep</month>
            <day>19</day>
            <volume>286</volume>
            <issue>11</issue>
            <fpage>1317</fpage>
            <page-range>1317-24</page-range>
            <pub-id pub-id-type="pmid">11560536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sontheimer</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Peripheral vascular disease: diagnosis and treatment.</article-title>
            <source>Am Fam Physician</source>
            <year>2006</year>
            <month>Jun</month>
            <day>01</day>
            <volume>73</volume>
            <issue>11</issue>
            <fpage>1971</fpage>
            <page-range>1971-6</page-range>
            <pub-id pub-id-type="pmid">16770929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harris</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Croce</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Thoracic aortic aneurysm.</article-title>
            <source>Ann Cardiothorac Surg</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>407</fpage>
            <pub-id pub-id-type="pmid">27563557</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aggarwal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Qamar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Abdominal aortic aneurysm: A comprehensive review.</article-title>
            <source>Exp Clin Cardiol</source>
            <year>2011</year>
            <season>Spring</season>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-5</page-range>
            <pub-id pub-id-type="pmid">21523201</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r44">
          <label>44</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Felner</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <chapter-title>An Overview of the Cardiovascular System</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Walker</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Hurst</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <source>Clinical Methods: The History, Physical, and Laboratory Examinations</source>
            <edition>3rd</edition>
            <publisher-name>Butterworths</publisher-name>
            <publisher-loc>Boston</publisher-loc>
            <year>1990</year>
            <pub-id pub-id-type="pmid">21250234</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Budoff</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Achenbach</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Blumenthal</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Goldin</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Greenland</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Guerci</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Lima</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Rader</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Rubin</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Wiegers</surname>
                <given-names>SE</given-names>
              </name>
              <collab>American Heart Association Committee on Cardiovascular Imaging and Intervention</collab>
              <collab>American Heart Association Council on Cardiovascular Radiology and Intervention</collab>
              <collab>American Heart Association Committee on Cardiac Imaging, Council on Clinical Cardiology</collab>
            </person-group>
            <article-title>Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology.</article-title>
            <source>Circulation</source>
            <year>2006</year>
            <month>Oct</month>
            <day>17</day>
            <volume>114</volume>
            <issue>16</issue>
            <fpage>1761</fpage>
            <page-range>1761-91</page-range>
            <pub-id pub-id-type="pmid">17015792</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kavousi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Leening</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Nanchen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Greenland</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Steyerberg</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Ikram</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Stricker</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Hofman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Franco</surname>
                <given-names>OH</given-names>
              </name>
            </person-group>
            <article-title>Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.</article-title>
            <source>JAMA</source>
            <year>2014</year>
            <month>Apr</month>
            <day>09</day>
            <volume>311</volume>
            <issue>14</issue>
            <fpage>1416</fpage>
            <page-range>1416-23</page-range>
            <pub-id pub-id-type="pmid">24681960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yancy</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Jessup</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bozkurt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Colvin</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Drazner</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Filippatos</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Fonarow</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Givertz</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Hollenberg</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Lindenfeld</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Masoudi</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>McBride</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Westlake</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.</article-title>
            <source>Circulation</source>
            <year>2017</year>
            <month>Aug</month>
            <day>08</day>
            <volume>136</volume>
            <issue>6</issue>
            <fpage>e137</fpage>
            <page-range>e137-e161</page-range>
            <pub-id pub-id-type="pmid">28455343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carvalho-Pinto</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Faria</surname>
                <given-names>CD</given-names>
              </name>
            </person-group>
            <article-title>Health, function and disability in stroke patients in the community.</article-title>
            <source>Braz J Phys Ther</source>
            <year>2016</year>
            <season>Jul-Aug</season>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>355</fpage>
            <page-range>355-66</page-range>
            <pub-id pub-id-type="pmid">27556392</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bovim</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Askim</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lydersen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fj&#x000e6;rtoft</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Indredavik</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Complications in the first week after stroke: a 10-year comparison.</article-title>
            <source>BMC Neurol</source>
            <year>2016</year>
            <month>Aug</month>
            <day>11</day>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>133</fpage>
            <pub-id pub-id-type="pmid">27515730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Criqui</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Langer</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Fronek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Feigelson</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Klauber</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>McCann</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Browner</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Mortality over a period of 10 years in patients with peripheral arterial disease.</article-title>
            <source>N Engl J Med</source>
            <year>1992</year>
            <month>Feb</month>
            <day>06</day>
            <volume>326</volume>
            <issue>6</issue>
            <fpage>381</fpage>
            <page-range>381-6</page-range>
            <pub-id pub-id-type="pmid">1729621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aronow</surname>
                <given-names>WS</given-names>
              </name>
            </person-group>
            <article-title>Peripheral arterial disease of the lower extremities.</article-title>
            <source>Arch Med Sci</source>
            <year>2012</year>
            <month>May</month>
            <day>09</day>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>375</fpage>
            <page-range>375-88</page-range>
            <pub-id pub-id-type="pmid">22662015</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ponikowski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Voors</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Anker</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Bueno</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cleland</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Coats</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Falk</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Juanatey</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Harjola</surname>
                <given-names>VP</given-names>
              </name>
              <name>
                <surname>Jankowska</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Jessup</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Linde</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nihoyannopoulos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Parissis</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Pieske</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Riley</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Rosano</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Ruilope</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Ruschitzka</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rutten</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>van der Meer</surname>
                <given-names>P</given-names>
              </name>
              <collab>Authors/Task Force Members</collab>
              <collab>Document Reviewers</collab>
            </person-group>
            <article-title>2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.</article-title>
            <source>Eur J Heart Fail</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>18</volume>
            <issue>8</issue>
            <fpage>891</fpage>
            <page-range>891-975</page-range>
            <pub-id pub-id-type="pmid">27207191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18939.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sandhoff</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Kuca</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Merenich</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Collaborative cardiac care service: a multidisciplinary approach to caring for patients with coronary artery disease.</article-title>
            <source>Perm J</source>
            <year>2008</year>
            <season>Summer</season>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>4</fpage>
            <page-range>4-11</page-range>
            <pub-id pub-id-type="pmid">21331203</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
